title: A report from the 20th United European Gastroenterology Week 2012 (October 20-24, 2012 - Amsterdam, the Netherlands).
abstract: This year saw the 20th anniversary of the first United European Gastroenterology Week (UEGW), the largest European conference focused on diseases of the stomach, bowel, esophagus, liver, pancreas and gallbladder. UEGW 2012, which was held in Amsterdam, the Netherlands, attracted over 14,000 delegates who discussed recent developments in the treatment of these diseases, including multidisciplinary care and the effect of obesity and alcohol on gastrointestinal and liver diseases.
authors.affiliation: Thomson Reuters, Barcelona, Spain. jaume.escorsell@thomsonreuters.com
authors.forename: J
authors.initials: J
authors.lastname: Escorsell
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003248:Constipation / Q000139:chemically induced / Q000188:drug therapy; D005762:Gastroenterology; D006801:Humans
chemical_list: D000701:Analgesics, Opioid; D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D019819:Budesonide; C543529:vedolizumab